Skip to Main content Skip to Navigation
Journal articles

Cell-free circulating epimarks in cancer monitoring

Abstract : Cancer numbers increasing, cases heterogeneity and the drug resistance emergence have pushed scientists to search for innovative solutions for patients and epimutations can be one. Methylated DNA, modified nucleosomes and noncoding RNAs are found in all cells, including tumor cells. They are intracellular actors but also have intercellular communication roles, being released in extracellular environment and in different body fluids. Here, we reviewed current literature on the use of these blood circulating epimarks in cancer monitoring. What stands out is that epimarkers must be considered as 'real time' images of the tumor, and can be isolated without invasive methods. In the future, the real challenge lies in the development of specific, sensitive, fast and clinically applicable detection and analysis methods of epimarkers.
Document type :
Journal articles
Complete list of metadata

Cited literature [125 references]  Display  Hide  Download
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Wednesday, February 19, 2020 - 3:57:24 PM
Last modification on : Wednesday, April 27, 2022 - 3:56:59 AM
Long-term archiving on: : Wednesday, May 20, 2020 - 3:50:09 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




Manon Duforestel, Josephine Briand, Gwenola Bougras-Cartron, Dominique Heymann, Jean-Sébastien Frenel, et al.. Cell-free circulating epimarks in cancer monitoring. Epigenomics, Future Medicine, 2020, 12 (2), pp.145-155. ⟨10.2217/epi-2019-0170⟩. ⟨inserm-02484725⟩



Record views